FELIX BAKER Insider Trading $GEVA SYNAGEVA BIOPHARMA CORP

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for FELIX BAKER.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of FELIX BAKER. FELIX BAKER is 10% Owner in BIOCRYST PHARMACEUTICALS INC ($BCRX) and Director in SYNAGEVA BIOPHARMA CORP ($GEVA) and Director in Ardea Biosciences, Inc./DE ($IBPI) and Director in ACADIA PHARMACEUTICALS INC ($ACAD) and Director in SEATTLE GENETICS INC /WA ($SGEN) and Director in GENOMIC HEALTH INC ($GHDX) and 10% Owner in Mirati Therapeutics, Inc. ($MYG).

FELIX BAKER in SYNAGEVA BIOPHARMA CORP

Trading Symbol: GEVA
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of FELIX BAKER: Director
Holdings: 9,184,771 shares
Latest Transaction: Jan 09 2015

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of FELIX BAKER in SYNAGEVA BIOPHARMA CORP

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Sentiment: All, ACAD, IBPI, BCRX, GHDX, MYG, SGEN, GEVA

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Jan 09 2015GEVASYNAGEVA BIOPHARMA ...BAKER FELIXDirectorBuyP94.191,000,00094,190,0009,184,7718.2 M to 9.2 M (+12.22 %)
Jun 24 2014GEVASYNAGEVA BIOPHARMA ...BAKER FELIXDirectorOption ExerciseM60.454,250256,9130
Jun 24 2014GEVASYNAGEVA BIOPHARMA ...BAKER FELIXDirectorOption ExerciseM60.454,250256,9130
Jun 24 2014GEVASYNAGEVA BIOPHARMA ...BAKER FELIXDirectorOption ExerciseM60.454,250256,9130
Jun 24 2014GEVASYNAGEVA BIOPHARMA ...BAKER FELIXDirectorOption ExerciseM60.454,250256,9130
Jun 24 2014GEVASYNAGEVA BIOPHARMA ...BAKER FELIXDirectorOption ExerciseM60.454,250256,9130
Jun 24 2014GEVASYNAGEVA BIOPHARMA ...BAKER FELIXDirectorOption ExerciseM60.454,250256,9130
Jun 24 2014GEVASYNAGEVA BIOPHARMA ...BAKER FELIXDirectorOption ExerciseM60.454,250256,9130
Jun 24 2014GEVASYNAGEVA BIOPHARMA ...BAKER FELIXDirectorBuyM60.454,250256,913223,864219.6 K to 223.9 K (+1.94 %)
Jun 24 2014GEVASYNAGEVA BIOPHARMA ...BAKER FELIXDirectorBuyM60.454,250256,9138,184,7718.2 M to 8.2 M (+0.05 %)
Jun 24 2014GEVASYNAGEVA BIOPHARMA ...BAKER FELIXDirectorBuyM60.454,250256,913112,740108.5 K to 112.7 K (+3.92 %)
Jun 24 2014GEVASYNAGEVA BIOPHARMA ...BAKER FELIXDirectorBuyM60.454,250256,9131,748,3151.7 M to 1.7 M (+0.24 %)
Jun 24 2014GEVASYNAGEVA BIOPHARMA ...BAKER FELIXDirectorBuyM60.454,250256,91367,72963.5 K to 67.7 K (+6.70 %)
Jun 24 2014GEVASYNAGEVA BIOPHARMA ...BAKER FELIXDirectorBuyM60.454,250256,913177,463173.2 K to 177.5 K (+2.45 %)
Jun 24 2014GEVASYNAGEVA BIOPHARMA ...BAKER FELIXDirectorBuyM60.454,250256,913219,050214.8 K to 219.1 K (+1.98 %)
Jun 06 2014GEVASYNAGEVA BIOPHARMA ...BAKER FELIXDirectorOption ExerciseA80.3515,0001,205,25015,000
Apr 25 2014GEVASYNAGEVA BIOPHARMA ...BAKER FELIXDirectorOption ExerciseM65.108,000520,8000
Apr 25 2014GEVASYNAGEVA BIOPHARMA ...BAKER FELIXDirectorOption ExerciseM65.108,000520,8000
Apr 25 2014GEVASYNAGEVA BIOPHARMA ...BAKER FELIXDirectorOption ExerciseM65.108,000520,8000
Apr 25 2014GEVASYNAGEVA BIOPHARMA ...BAKER FELIXDirectorOption ExerciseM65.108,000520,8000
Apr 25 2014GEVASYNAGEVA BIOPHARMA ...BAKER FELIXDirectorOption ExerciseM65.108,000520,8000
Apr 25 2014GEVASYNAGEVA BIOPHARMA ...BAKER FELIXDirectorOption ExerciseM65.108,000520,8000
Apr 25 2014GEVASYNAGEVA BIOPHARMA ...BAKER FELIXDirectorOption ExerciseM65.108,000520,8000
Apr 25 2014GEVASYNAGEVA BIOPHARMA ...BAKER FELIXDirectorBuyM65.108,000520,800219,614211.6 K to 219.6 K (+3.78 %)
Apr 25 2014GEVASYNAGEVA BIOPHARMA ...BAKER FELIXDirectorBuyM65.108,000520,8008,180,5218.2 M to 8.2 M (+0.10 %)
Apr 25 2014GEVASYNAGEVA BIOPHARMA ...BAKER FELIXDirectorBuyM65.108,000520,800108,490100.5 K to 108.5 K (+7.96 %)
Apr 25 2014GEVASYNAGEVA BIOPHARMA ...BAKER FELIXDirectorBuyM65.108,000520,8001,744,0651.7 M to 1.7 M (+0.46 %)
Apr 25 2014GEVASYNAGEVA BIOPHARMA ...BAKER FELIXDirectorBuyM65.108,000520,80063,47955.5 K to 63.5 K (+14.42 %)
Apr 25 2014GEVASYNAGEVA BIOPHARMA ...BAKER FELIXDirectorBuyM65.108,000520,800173,213165.2 K to 173.2 K (+4.84 %)
Apr 25 2014GEVASYNAGEVA BIOPHARMA ...BAKER FELIXDirectorBuyM65.108,000520,800214,800206.8 K to 214.8 K (+3.87 %)
Mar 07 2014GEVASYNAGEVA BIOPHARMA ...BAKER FELIXDirectorBuyP105.759,031955,028211,614202.6 K to 211.6 K (+4.46 %)
Mar 07 2014GEVASYNAGEVA BIOPHARMA ...BAKER FELIXDirectorBuyP105.75365,96938,701,2228,172,5217.8 M to 8.2 M (+4.69 %)
Sep 27 2013GEVASYNAGEVA BIOPHARMA ...BAKER FELIXDirectorBuyP56.6325,6631,453,296202,583176.9 K to 202.6 K (+14.51 %)
Sep 27 2013GEVASYNAGEVA BIOPHARMA ...BAKER FELIXDirectorBuyP56.631,024,33758,008,2047,806,5526.8 M to 7.8 M (+15.10 %)
Jun 10 2013GEVASYNAGEVA BIOPHARMA ...BAKER FELIXDirectorOption ExerciseA40.3215,000604,80015,000
Jun 10 2013GEVASYNAGEVA BIOPHARMA ...BAKER FELIXDirectorOption ExerciseA40.3215,000604,80015,000
Jun 10 2013GEVASYNAGEVA BIOPHARMA ...BAKER FELIXDirectorOption ExerciseA40.3215,000604,80015,000
Jun 10 2013GEVASYNAGEVA BIOPHARMA ...BAKER FELIXDirectorOption ExerciseA40.3215,000604,80015,000
Jun 10 2013GEVASYNAGEVA BIOPHARMA ...BAKER FELIXDirectorOption ExerciseA40.3215,000604,80015,000
Jun 10 2013GEVASYNAGEVA BIOPHARMA ...BAKER FELIXDirectorOption ExerciseA40.3215,000604,80015,000
Jun 10 2013GEVASYNAGEVA BIOPHARMA ...BAKER FELIXDirectorOption ExerciseA40.3215,000604,80015,000
Jan 08 2013GEVASYNAGEVA BIOPHARMA ...BAKER FELIXDirectorBuyP47.5320,099955,305176,920156.8 K to 176.9 K (+12.82 %)
Jan 08 2013GEVASYNAGEVA BIOPHARMA ...BAKER FELIXDirectorBuyP47.53839,62139,907,1866,782,2155.9 M to 6.8 M (+14.13 %)
Jul 13 2012GEVASYNAGEVA BIOPHARMA ...BAKER FELIXDirectorBuyP41.2021,082868,578156,821135.7 K to 156.8 K (+15.53 %)
Jul 13 2012GEVASYNAGEVA BIOPHARMA ...BAKER FELIXDirectorBuyP41.20864,91835,634,6225,942,5945.1 M to 5.9 M (+17.03 %)
Jun 29 2012GEVASYNAGEVA BIOPHARMA ...BAKER FELIXDirectorOption ExerciseA40.747,500305,5507,500
Nov 04 2011GEVASYNAGEVA BIOPHARMA ...BAKER FELIXDirectorOption ExerciseA2,350.0012,3501
Nov 04 2011GEVASYNAGEVA BIOPHARMA ...BAKER FELIXDirectorOption ExerciseA2,350.0012,3501
Nov 04 2011GEVASYNAGEVA BIOPHARMA ...BAKER FELIXDirectorGrantA0.00135,4620143,9628.5 K to 144 K (+1,593.67 %)

Page:   1